These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome. Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629 [TBL] [Abstract][Full Text] [Related]
36. Factors Associated With the Need for Pharmacological Management of Neonatal Opioid Withdrawal Syndrome. Scott LF; Guilfoy V; Duwve JM; Rawl SM Adv Neonatal Care; 2020 Oct; 20(5):364-373. PubMed ID: 32868586 [TBL] [Abstract][Full Text] [Related]
37. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine. O'Connor AB; Kelly BK; O'Brien LM Drug Alcohol Depend; 2017 Nov; 180():200-203. PubMed ID: 28917206 [TBL] [Abstract][Full Text] [Related]
38. Avoiding NICU Transfers for Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS): A Quality Improvement Initiative to Manage NOWS on the Mother-baby Unit. Spence K; Boedeker R; Harhausen M; Kaushal G; Buchanan P; Josephsen J J Addict Med; 2020; 14(5):401-408. PubMed ID: 31972766 [TBL] [Abstract][Full Text] [Related]
39. Characteristics and outcomes of neonatal opioid withdrawal syndrome in preterm infants: a retrospective cohort study in the current era. Heyward A; Minich N; Hoffman AC; Hibbs AM; Zhao L; Crowley M J Perinatol; 2023 Jul; 43(7):909-915. PubMed ID: 37188773 [TBL] [Abstract][Full Text] [Related]
40. Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder. Kanervo MM; Tupola SJ; Nikkola EM; Rantakari KM; Kahila HK Acta Obstet Gynecol Scand; 2023 Mar; 102(3):313-322. PubMed ID: 36562462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]